Updated investor presentation

Oslo, 21 January 2010 - Attached is an updated investor presentation of PCI Biotech.  The presentation will be used in meetings with potential investors in London today, 21(st) January 2010. Contact information: PCI Biotech Holding ASA, Strandveien 55, N-1366 Lysaker Per Walday, CEO, pw@pcibiotech.no, Mobile: +47 917 93 429 Bernt-Olav Røttingsnes, CFO, bor@pcibiotech.no, Mobile: +47 913 47 021 This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act) [HUG#1375439] PCI Biotech Investor Presentation: http://hugin.info/139147/R/1375439/337451.pdf